Archives for 02/10/2022

– Manuscript – Drugmakers Biogen and Eisai say their experimental drug lecanemab slowed the progress of Alzheimer’s disease in a large human study the companies did. The results could mean a rare victory in a field filled with failed experiments to find an effective treatment for the disease. The companies said early results showed that the treatment reduced cognitive … [Read more...] about Experimental Drug Slows Decline among Alzheimer’s Patients